NDC 17856-2133-2 - POSACONAZOLE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-2133
- Requested NDC
- 17856-2133-2
- Package NDCs from labels
- 17856-2133-2, 17856-2133-1, 17856-2133-5
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-04-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POSACONAZOLE - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-04-20 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-2133-1 | POSACONAZOLE | 100 in 1 BOX, UNIT-DOSE | TABLET, DELAYED RELEASE | 100 | 4 | |
| 17856-2133-2 | POSACONAZOLE | 1 in 1 POUCH | TABLET, DELAYED RELEASE | 1 | 4 | |
| 17856-2133-5 | POSACONAZOLE | 1 in 1 POUCH | TABLET, DELAYED RELEASE | 1 | 4 | |
| 17856-2133-5 | POSACONAZOLE | 59 in 1 BOX | TABLET, DELAYED RELEASE | 59 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-2133 | POSACONAZOLE TABLET, DELAYED RELEASE [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 4 package rows | 20240510_dfbc636f-d8a7-4232-a6b0-cda49caadc9b.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.